Screener
Mineralys Therapeutics, Inc. MLYS PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 5:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001933414-26-000084
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Investments | 533,281 | 483,714 |
| Prepaid and other current assets | 6,410 | 4,751 |
| Total current assets | 652,470 | 661,386 |
| Property and equipment, net | 32 | 38 |
| Other assets | 360 | 382 |
| Total assets | $652,862 | $661,806 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: |
Item 1. Financial Statements
FAQ
- What is Mineralys Therapeutics, Inc.'s PP&E (net)?
- Mineralys Therapeutics, Inc. (MLYS) reported PP&E (net) of $32K in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s PP&E (net) changed year-over-year?
- Mineralys Therapeutics, Inc.'s PP&E (net) decreased by 15.8% year-over-year, from $38K to $32K.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Mineralys Therapeutics, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude